MasterClass: Unlocking the Doors of Depression: Neuroplastic and Psychedelic Therapies in MDD

Advances in neuroplasticity research are reshaping the future of depression treatment. This session examines glutamatergic and serotonergic pathways, reviews the latest evidence surrounding investigational psychedelic therapies and psychedelic-assisted psychotherapy, and discusses their potential role within the evolving treatment landscape for MDD.

Supported by an educational grant from AbbVie Inc.